Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.

Erdur H, Scholz V, Streitz M, Hammer M, Meisel C, Schönemann C, Wandinger KP, Rosche B.

J Neuroimmunol. 2016 May 15;294:14-7. doi: 10.1016/j.jneuroim.2016.03.010. Epub 2016 Mar 19.

PMID:
27138093
2.

[Biomarkers for the diagnosis of fatigue in patients with multiple sclerosis].

Rosche B.

Versicherungsmedizin. 2015 Sep 1;67(3):148-51. German. No abstract available.

PMID:
26548013
3.

Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis.

Stascheit F, Paul F, Harms L, Rosche B.

J Neuroimmunol. 2015 Aug 15;285:119-24. doi: 10.1016/j.jneuroim.2015.05.011. Epub 2015 May 15.

PMID:
26198927
4.

Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis.

Fleischmann R, Prüss H, Rosche B, Bahnemann M, Gelderblom H, Deuschle K, Harms L, Kopp U, Ruprecht K.

JAMA Neurol. 2015 Jan;72(1):96-9. doi: 10.1001/jamaneurol.2014.1817.

PMID:
25384024
5.

Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.

Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, Reimer U, Scheibenbogen C.

J Neuroimmunol. 2014 Jul 15;272(1-2):56-61. doi: 10.1016/j.jneuroim.2014.04.005. Epub 2014 Apr 16.

PMID:
24798244
6.

Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.

Kuchling J, Ramien C, Bozin I, Dörr J, Harms L, Rosche B, Niendorf T, Paul F, Sinnecker T, Wuerfel J.

Mult Scler. 2014 Dec;20(14):1866-71. doi: 10.1177/1352458514531084. Epub 2014 Apr 29.

PMID:
24781284
7.

Coal-packed methane biofilter for mitigation of green house gas emissions from coal mine ventilation air.

Limbri H, Gunawan C, Thomas T, Smith A, Scott J, Rosche B.

PLoS One. 2014 Apr 17;9(4):e94641. doi: 10.1371/journal.pone.0094641. eCollection 2014.

8.

Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.

Rosche B, Werner J, Benzel FJ, Harms L, Danker-Hopfe H, Hellweg R.

Parasite. 2013;20:55. doi: 10.1051/parasite/2013056. Epub 2013 Dec 19.

9.

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.

Rosche B, Wernecke KD, Ohlraun S, Dörr JM, Paul F.

Trials. 2013 Apr 25;14:112. doi: 10.1186/1745-6215-14-112.

10.

Catalytic biofilms on structured packing for the production of glycolic acid.

Li XZ, Hauer B, Rosche B.

J Microbiol Biotechnol. 2013 Feb;23(2):195-204.

11.

Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.

Prüss H, Rosche B, Sullivan AB, Brommer B, Wengert O, Gronert K, Schwab JM.

PLoS One. 2013;8(2):e55859. doi: 10.1371/journal.pone.0055859. Epub 2013 Feb 8.

12.

Crystal structure determination and mutagenesis analysis of the ene reductase NCR.

Reich S, Hoeffken HW, Rosche B, Nestl BM, Hauer B.

Chembiochem. 2012 Nov 5;13(16):2400-7. doi: 10.1002/cbic.201200404. Epub 2012 Oct 2.

PMID:
23033175
13.

Ethylene glycol metabolism by Pseudomonas putida.

Mückschel B, Simon O, Klebensberger J, Graf N, Rosche B, Altenbuchner J, Pfannstiel J, Huber A, Hauer B.

Appl Environ Microbiol. 2012 Dec;78(24):8531-9. doi: 10.1128/AEM.02062-12. Epub 2012 Sep 28.

14.

Breastfeeding is associated with lower risk for multiple sclerosis.

Conradi S, Malzahn U, Paul F, Quill S, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B.

Mult Scler. 2013 Apr;19(5):553-8. doi: 10.1177/1352458512459683. Epub 2012 Sep 4.

PMID:
22951352
15.

Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis.

Rosche B, Laurent S, Conradi S, Hofmann J, Ruprecht K, Harms L.

PLoS One. 2012;7(1):e28094. doi: 10.1371/journal.pone.0028094. Epub 2012 Jan 19.

16.

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study.

Conradi S, Malzahn U, Schröter F, Paul F, Quill S, Spruth E, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B.

BMC Neurol. 2011 Oct 6;11:123. doi: 10.1186/1471-2377-11-123.

17.

Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients.

Benzel F, Erdur H, Kohler S, Frentsch M, Thiel A, Harms L, Wandinger KP, Rosche B.

J Helminthol. 2012 Sep;86(3):339-47. doi: 10.1017/S0022149X11000460. Epub 2011 Aug 15.

PMID:
21838960
18.

Effect of gcl, glcB and aceA disruption on glyoxylate conversion by Pseudomonas putida JM37.

Li XZ, Klebensberger J, Rosche B.

J Microbiol Biotechnol. 2010 Jun;20(6):1006-10.

19.

Microbial biofilms: a concept for industrial catalysis?

Rosche B, Li XZ, Hauer B, Schmid A, Buehler K.

Trends Biotechnol. 2009 Nov;27(11):636-43. doi: 10.1016/j.tibtech.2009.08.001. Epub 2009 Sep 23. Review.

PMID:
19783314
20.

Response of Saccharomyces cerevisiae to stress-free acidification.

Chen AK, Gelling C, Rogers PL, Dawes IW, Rosche B.

J Microbiol. 2009 Feb;47(1):1-8. doi: 10.1007/s12275-008-0167-2. Epub 2009 Feb 20.

PMID:
19229485
21.

Improved (R)-phenylacetylcarbinol production with Candida utilis pyruvate decarboxylase at decreased organic to aqueous phase volume ratios.

Gunawan C, Breuer M, Hauer B, Rogers PL, Rosche B.

Biotechnol Lett. 2008 Feb;30(2):281-6. Epub 2007 Sep 18.

PMID:
17876535
22.

Asymmetric alkene reduction by yeast old yellow enzymes and by a novel Zymomonas mobilis reductase.

Müller A, Hauer B, Rosche B.

Biotechnol Bioeng. 2007 Sep 1;98(1):22-9.

PMID:
17657768
23.

Single-species microbial biofilm screening for industrial applications.

Li XZ, Hauer B, Rosche B.

Appl Microbiol Biotechnol. 2007 Oct;76(6):1255-62. Epub 2007 Jul 26.

PMID:
17653709
24.

[The role of uveitis in demyelinating diseases of the central nervous system].

Beyer AM, Rosche B, Pleyer U, Wandinger KP.

Nervenarzt. 2007 Dec;78(12):1389-98. Review. German.

PMID:
17549445
25.

Stereospecific alkyne reduction: novel activity of old yellow enzymes.

Müller A, Stürmer R, Hauer B, Rosche B.

Angew Chem Int Ed Engl. 2007;46(18):3316-8. No abstract available.

PMID:
17387664
26.

Yeast pyruvate decarboxylases: variation in biocatalytic characteristics for (R)-phenylacetylcarbinol production.

Gunawan C, Satianegara G, Chen AK, Breuer M, Hauer B, Rogers PL, Rosche B.

FEMS Yeast Res. 2007 Jan;7(1):33-9.

27.
28.

Enhanced benzaldehyde tolerance in Zymomonas mobilis biofilms and the potential of biofilm applications in fine-chemical production.

Li XZ, Webb JS, Kjelleberg S, Rosche B.

Appl Environ Microbiol. 2006 Feb;72(2):1639-44. Erratum in: Appl Environ Microbiol. 2006 Aug;72(8):5678.

29.

Enzymatic (R)-phenylacetylcarbinol production in a benzaldehyde emulsion system with Candida utilis cells.

Satianegara G, Breuer M, Hauer B, Rogers PL, Rosche B.

Appl Microbiol Biotechnol. 2006 Mar;70(2):170-5. Epub 2005 Sep 13.

PMID:
16158280
30.

pH shift enhancement of Candida utilis pyruvate decarboxylase production.

Chen AK, Breuer M, Hauer B, Rogers PL, Rosche B.

Biotechnol Bioeng. 2005 Oct 20;92(2):183-8.

PMID:
15977252
31.

Cells of Candida utilis for in vitro (R)-phenylacetylcarbinol production in an aqueous/octanol two-phase reactor.

Rosche B, Breuer M, Hauer B, Rogers PL.

Biotechnol Lett. 2005 Apr;27(8):575-81.

PMID:
15973492
32.

(R)-phenylacetylcarbinol production in aqueous/organic two-phase systems using partially purified pyruvate decarboxylase from Candida utilis.

Sandford V, Breuer M, Hauer B, Rogers P, Rosche B.

Biotechnol Bioeng. 2005 Jul 20;91(2):190-8.

PMID:
15892055
33.

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, Sommer N, Hartung HP, Hemmer B.

Brain. 2005 Jul;128(Pt 7):1667-76. Epub 2005 Mar 30.

PMID:
15800022
34.

Role of pyruvate in enhancing pyruvate decarboxylase stability towards benzaldehyde.

Rosche B, Breuer M, Hauer B, Rogers PL.

J Biotechnol. 2005 Jan 12;115(1):91-9.

PMID:
15607228
35.

The role of the polio virus receptor and the herpesvirus entry mediator B genes for the development of MS.

Rosche B, Cepok S, Stei S, Vogel F, Grummel V, Hoffmann S, Kroner A, Mäurer M, Rieckmann P, Sommer N, Hemmer B.

J Neuroimmunol. 2004 Nov;156(1-2):171-7.

PMID:
15465608
36.

Kinetic analysis and modelling of enzymatic (R)-phenylacetylcarbinol batch biotransformation process.

Leksawasdi N, Chow YY, Breuer M, Hauer B, Rosche B, Rogers PL.

J Biotechnol. 2004 Jul 15;111(2):179-89.

PMID:
15219404
37.

Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis.

Kroner A, Mäurer M, Loserth S, Kleinschnitz C, Hemmer B, Rosche B, Toyka KV, Rieckmann P.

Tissue Antigens. 2004 Jul;64(1):70-3.

PMID:
15191525
38.

Myositis in a patient with large granular leukocyte leukemia.

Rosche B, Jacobsen M, Cepok S, Barth P, Sommer N, Hemmer B.

Muscle Nerve. 2004 Jun;29(6):873-7.

PMID:
15170622
39.

Biphasic aqueous/organic biotransformation of acetaldehyde and benzaldehyde by Zymomonas mobilis pyruvate decarboxylase.

Rosche B, Breuer M, Hauer B, Rogers PL.

Biotechnol Bioeng. 2004 Jun 30;86(7):788-94.

PMID:
15162454
40.

Effects of taurine and glycine on epileptiform activity induced by removal of Mg2+ in combined rat entorhinal cortex-hippocampal slices.

Kirchner A, Breustedt J, Rosche B, Heinemann UF, Schmieden V.

Epilepsia. 2003 Sep;44(9):1145-52.

41.

[New understanding of the immunopathogenesis of multiple sclerosis].

Rosche B, Kieseier B, Hartung HP, Hemmer B.

Nervenarzt. 2003 Aug;74(8):654-63. Review. German.

PMID:
12904867
42.

Increased pyruvate efficiency in enzymatic production of (R)-phenylacetylcarbinol.

Rosche B, Breuer M, Hauer B, Rogers PL.

Biotechnol Lett. 2003 Jun;25(11):847-51.

PMID:
12889792
43.

Screening of yeasts for cell-free production of (R)-phenylacetylcarbinol.

Rosche B, Breuer M, Hauer B, Rogers PL.

Biotechnol Lett. 2003 Jun;25(11):841-5.

PMID:
12889791
44.

The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis.

Cepok S, Zhou D, Vogel F, Rosche B, Grummel V, Sommer N, Hemmer B.

Arch Neurol. 2003 Jun;60(6):849-55.

PMID:
12810490
45.

Enzymatic (R)-phenylacetylcarbinol production in benzaldehyde emulsions.

Rosche B, Leksawasdi N, Sandford V, Breuer M, Hauer B, Rogers P.

Appl Microbiol Biotechnol. 2002 Oct;60(1-2):94-100. Epub 2002 Jul 30.

PMID:
12382047
46.

Biotransformation of benzaldehyde into (R)-phenylacetylcarbinol by filamentous fungi or their extracts.

Rosche B, Sandford V, Breuer M, Hauer B, Rogers P.

Appl Microbiol Biotechnol. 2001 Oct;57(3):309-15.

PMID:
11759677
47.

2-oxo-1,2-dihydroquinoline 8-monooxygenase: phylogenetic relationship to other multicomponent nonheme iron oxygenases.

Rosche B, Tshisuaka B, Hauer B, Lingens F, Fetzner S.

J Bacteriol. 1997 Jun;179(11):3549-54.

48.

The 2Fe2S centres of the 2-oxo-1,2-dihydroquinoline 8-monooxygenase from Pseudomonas putida 86 studied by EPR spectroscopy.

Rosche B, Fetzner S, Lingens F, Nitschke W, Riedel A.

Biochim Biophys Acta. 1995 Oct 25;1252(2):177-9.

PMID:
7578219
49.

2-Oxo-1,2-dihydroquinoline 8-monooxygenase, a two-component enzyme system from Pseudomonas putida 86.

Rosche B, Tshisuaka B, Fetzner S, Lingens F.

J Biol Chem. 1995 Jul 28;270(30):17836-42.

Supplemental Content

Loading ...
Support Center